A unique opportunity to advance research into the function of the human brain has been presented to three UCLA neuroscientists. Michele Basso, Dr. Peyman Golshani and Daniel Aharoni have received a $3.7 million, three-year grant from the National Institutes of Health (NIH) to develop imaging technology to record tens of thousands of neurons with the intent of learning how disease impacts the brain’s function.
Read MoreTags: UCLA, new research funding, NIH funding, LAVS, Biotechnology Vendor Showcase, CA, UCLA research funding, nih research funding, UCLA Funding statistics, UCLA School of Public Health, brain cancer treatment, lab equipment suppliers, Mental Disorders, Healthcare Research, Brain Disease, Neurological Research, university research funding
Two UCLA research programs have earned state and federal grants totaling $18.8 million, while two departments have been given $3.35 million in private endowments, according to university news reports. The Urology Department received $9.3 million from the state of California while the Fielding School of Public Health earned a $9.5 million grant from the National Institute of Drug Abuse (NIDA).
Read MoreTags: UCLA, new research funding, NIH funding, LAVS, Biotechnology Vendor Showcase, CA, UCLA research funding, nih research funding, UCLA Funding statistics, UCLA School of Public Health, Prostate cancer research, cancer reserach, HIV research
An estimated 15 million Americans will develop Alzheimer’s disease by 2060, according to researchers at the UCLA Fielding School of Public Health. The December 2017 study is the first of its kind to estimate the numbers of Americans with preclinical Alzheimer’s disease.
Read More
Tags: UCLA, new research funding, NIH funding, LAVS, Biotechnology Vendor Showcase, CA, cytomegalovirus, UCLA research funding, UCLA School of Public Health, Geriatrics, Alzheimer's Research, Alzheimer's research market
A $150 million gift to the University of Michigan will boost Michigan Medicine’s cancer research efforts, enabling the school to attract researchers from around the world as well as develop the next generation of researchers. The gift from alum Richard Roger and his wife, Susan, is one of the largest in the university’s history. In recognition of their many years of giving and service, the Comprehensive Cancer Center was renamed the Rogel Cancer Center by the U-M Regents in March.
Read MoreTags: University of Michigan, University of Michigan Ann Arbor, Michigan, MI, Midwest Region, UMich, University of Michigan research, University Research, university research funding, new research funding, laboratory equipment suppliers, BioResearch Product Faire, cancer reserach
Richard and Susan Rogal recently committed $150,000,000 to the University of Michigan Comprehensive Cancer Center. It is the largest gift ever been made to Michigan Medicine. The money will be used to support promising cancer research and help train the next generation of researchers.
Read MoreTags: University of Michigan, University of Michigan Ann Arbor, Michigan, MI, Midwest Region, UMich, research news, 2017 research funding, NIH awards 2017, University of Michigan research, University Research, university research funding, new research funding, laboratory equipment suppliers, BioResearch Product Faire, cancer research grant, cancer reserach, cancer research funding
The University of Michigan Center for the Discovery of New Medicines (CDNM) has awarded research funding to seven faculty members from across the U-M campus for new drug development projects. The goal of University of Michigan’s CDNM is to accelerate the path toward commercialization for novel and translational approaches to potential therapies. They do this by assisting investigators with financial support as well as providing guidance and expertise. Pilot grants of up to $50,000 are awarded twice per year. They are chosen based on scientific strength, commercial opportunity and unmet medical need.
Read MoreTags: University of Michigan, University of Michigan Ann Arbor, Michigan, MI, Midwest Region, UMich, research news, 2017 research funding, NIH awards 2017, University of Michigan research, University Research, university research funding, new research funding, laboratory equipment suppliers, BioResearch Product Faire
The Jan and Dan Duncan Neurological Research Institute (NRI) at Texas Childrens Hospital in Houston is a leading research institution continuously making breakthroughs in the field of neurological research on topics such as autism, Alzheimer's and epilepsy. Now, thanks to Charif Souki, co-founder of Tellurian, the NRI will have an additional $10 million to further their life science research. (Image courtesy of Zereshk via Wikimedia Commons)
Read MoreTags: tmc, Houston, TX, BioResearch Product Faire Event, Texas Childrens Hospital, Neurological Disorder, Neurological Research, new research funding
According to the National Science Foundation, The University of Michigan (UM) has ranked number one in total research spending among public universities in the United States for the past seven years. Just as impressive, the $1.48 billion spent in 2016/2017 represents a 6.4% increase over the previous finical year. Much of the university's funding came from federal grants.
Read MoreTags: University of Michigan, University of Michigan Ann Arbor, Michigan, MI, Midwest Region, New research facilities, UMich, research news, 2017 research funding, NIH awards 2017, University of Michigan research, University Research, university research funding, new research funding, laboratory equipment suppliers, BioResearch Product Faire
Of the four main types of Leukemia, Acute Myeloid Leukemia (AML) diagnoses make up nearly one-third of new leukemia cases and is most likely to occur in adults. Although common cancer treatment methods are used for AML patients, only about half go into remission after chemotherapy treatments. Factors such as age and overall health contribute to these remission rates. Researchers at top life science institutions around the world continually study AML to gain better understandings of the biology of this cancer that can lead to new and more effect treatment methods. (Image courtesy Wikimedia Commons)
Read MoreTags: 2018, SDVS, Biotechnology Vendor Showcase, UCSD, cancer research, cancer research funding, new research funding, Leukemia, Acute Myeloid Leukemia, AML Research, CA, San Diego
Tuberculosis (TB) is an infectious disease that affects nearly 1/3 of the world's population. Although eradication efforts have been undertaken, none have been successful and TB is still a leading cause around the world. Even though there are treatment methods for this infection, they are not always successful at killing the bacteria that cause TB. This provides life science researchers with more questions and research topics, to better understand the infection and bacteria and what causes treatments to work occasionally, but not always
Read MoreTags: 2018, UMASS, University of Massachusetts Amherst, Amherst, MA, tuberculosis, TB Research, NIH funding, new research funding
